A decision-making model for prediction of a stable disease course in chronic hepatitis B patients
Abstract Patients with chronic hepatitis B (CHB) are regularly monitored for HBV DNA and liver enzymes in order to assess disease progression and the need for antiviral therapy. Identifying patients with a stable course of disease can potentially prolong the intervals between visits, withhold unnece...
Main Authors: | Imri Ofri, Noam Peleg, Moshe Leshno, Amir Shlomai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50460-2 |
Similar Items
-
Advances and Challenges in Studying Hepatitis B Virus In Vitro
by: Dvora Witt-Kehati, et al.
Published: (2016-01-01) -
Multilayer feedward networks with a nonpolynomial activation function can approximate any function /
by: Leshno, Moshe -
THE COURSE OF CHRONIC HEPATITIS B IN INFANTS BORN TO MOTHERS WITH HBV-INFECTION
by: L. G. Goriacheva, et al.
Published: (2015-09-01) -
Genetic characteristics of the course of chronic hepatitis
by: Talipova Noila, et al.
Published: (2023-01-01) -
Chronic viral hepatitis B and D in pregnant women: course and outcomes (review)
by: M. D. Akhmedova, et al.
Published: (2021-07-01)